Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.63 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.63 |
| ▸ | THRA | P10827 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA3 | P07451 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 2/20 | 0.50 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL28142316 | 0.96 | GABRA1 (0.59) | GABRA1GABRB1THRATHRBCA1 | |
| SCHEMBL15524731 | 0.90 | CA1 (0.61) | GABRA1GABRB1THRATHRBCA1 | |
| SCHEMBL22005119 | 0.88 | GABRA1 (0.51) | GABRA1GABRB1THRATHRBCA1 | |
| SCHEMBL22004162 | 0.86 | TTR (0.64) | GABRA1GABRB1THRATHRBCA1 | |
| SCHEMBL14273021 | 0.85 | GABRA1 (0.49) | GABRA1GABRB1THRATHRBCA1 | |
| SCHEMBL28260303 | 0.84 | GABRA1 (0.49) | GABRA1GABRB1THRATHRBCA1 | |
| SCHEMBL28260301 | 0.84 | GABRA1 (0.49) | GABRA1GABRB1THRATHRBCA1 | |
| SCHEMBL28078271 | 0.84 | GABRA1 (0.78) | GABRA1GABRB1CA1CA2GABRB2 | |
| SCHEMBL10554155 | 0.83 | GLRA3 (0.50) | GABRA1GABRB1THRATHRBCA1 | |
| Acetic Acid SCHEMBL1928603 | 0.83 | GABRA1 (0.59) | GABRA1GABRB1THRATHRBCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059116-A1 | PROCESS FOR PRODUCING PROPOFOL | PCAS (FR) | 2025-02-20 | — | — | US | claimed |
| WO-2023111488-A1 | PROCESS FOR PRODUCING PROPOFOL | PCAS (FR) | 2023-06-22 | — | — | WO | claimed |
| US-20230174444-A1 | PROCESS FOR THE PREPARATION OF PROPOFOL | FRESENIUS KABI ONCOLOGY LTD. (IN) | 2023-06-08 | — | — | US | claimed |
| EP-4126803-A1 | PROCESS FOR THE PREPARATION OF PROPOFOL | Fresenius Kabi Oncology Limited (IN) | 2023-02-08 | — | — | EP | claimed |
| WO-2021191832-A1 | PROCESS FOR THE PREPARATION OF PROPOFOL | FRESENIUS KABI ONCOLOGY LTD. (IN) | 2021-09-30 | — | — | WO | claimed |
| EP-2516369-B1 | PROCESS FOR PREPARING EXTRA PURE 2, 6-DIISOPROPYL PHENOL | HARMAN FINOCHEM LTD (IN) | 2015-07-22 | — | — | EP | claimed |
| US-8664452-B2 | Process for preparing extra pure 2, 6-diisopropyl phenol | HARMAN FINOCHEM LIMITED (US) | 2014-03-04 | — | — | US | claimed |
| US-20130072573-A1 | PROCESS FOR PREPARING EXTRA PURE 2, 6-DIISOPROPYL PHENOL | HARMAN FINOCHEM LIMITED (IN) | 2013-03-21 | — | — | US | claimed |
| EP-2516369-A1 | PROCESS FOR PREPARING EXTRA PURE 2, 6-DIISOPROPYL PHENOL | Harman Finochem Limited (IN) | 2012-10-31 | — | — | EP | claimed |
| WO-2011161687-A1 | PROCESS FOR PREPARING EXTRA PURE 2, 6-DIISOPROPYL PHENOL | HARMAN FINOCHEM LIMITED (IN) | 2011-12-29 | — | — | WO | claimed |
| US-5702887-A | BENZ(B)ACRIDINIUM-12-CARBOXYLATE COMPOUNDS | CHIRON DIAGNOSTICS CORPORATION (US) | 1997-12-30 | — | — | US | claimed |
| US-20250059116-A1 | PROCESS FOR PRODUCING PROPOFOL | PCAS (FR) | 2025-02-20 | — | — | US | disclosed |
| US-20250059116-A1 | PROCESS FOR PRODUCING PROPOFOL | PCAS (FR) | 2025-02-20 | — | — | US | disclosed |
| EP-4448475-A1 | PROCESS FOR PRODUCING PROPOFOL | PCAS (FR) | 2024-10-23 | — | — | EP | disclosed |
| WO-2024186986-A1 | SELF-OPTIMIZING REGRESSION MODEL | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2024-09-12 | — | — | WO | disclosed |
| US-4255304-A | DISCOLORATION INHIBITION | AMERICAN CYANAMID COMPANY (US) | 1981-03-10 | — | — | US | disclosed |
| US-4248594-A | PRINTING, DYEING NICKEL SALTS OF 4-HYDROXYBENZOIC ACIDS | AMERICAN CYANAMID COMPANY (US) | 1981-02-03 | — | — | US | disclosed |
| US-4144029-A | PREPARED BY REACTION OF A NICKEL P-HYDROXYBENZOATE WITH AN ORGANIC PHOSPHITE | AMERICAN CYANAMID COMPANY (US) | 1979-03-13 | — | — | US | disclosed |
| US-4072707-A | Preparation of 3,5-dialkyl-4-hydroxybenzoic acid | AMERICAN CYANAMID COMPANY (US) | 1978-02-07 | — | — | US | disclosed |
| US-4011196-A | STABILIZED POLYESTER RESIN AND PROCESSES FOR MAKING THEM | FMC CORPORATION (US) | 1977-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174444-A1 | PROCESS FOR THE PREPARATION OF PROPOFOL | CYP3A4, CYP3A5, GABARAPL1 | GABRA1 18/4885GABRB1 31/4885THRA 1882/4885 |
| US-20130072573-A1 | PROCESS FOR PREPARING EXTRA PURE 2, 6-DIISOPROPYL PHENOL | CYP2B6, CYP2D6, CYP2A6 | GABRA1 133/4885GABRB1 200/4885THRA 2608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.